The company was established in 1998 12 18, with its headquarters in Changde City, Hunan Province, and its legal representative is Ye, mainly engaged in pharmaceutical manufacturing. The registered place is located at No.661Taolin Road, Shuanggang Community, Zhangmuqiao Street, Changde Economic and Technological Development Zone, Hunan Province (Shuangchuang Building/Room KLOC-0/703). The registered capital of the company is 87977.43565438 yuan+00,000 yuan, and the paid-in capital is 65438 yuan +0900065438 yuan+02,000 yuan. In 2022, the private placement was completed.

Hunan Jingfeng Pharmaceutical Co., Ltd. was listed on February 20 14 and 14. Adhering to the concept of "solid foundation, scientific and technological innovation and sustainable development", the company adheres to the road of industrialization of high-end generic drugs with international characteristics. Now it has 22 wholly-owned and holding subsidiaries in Shanghai, Guizhou, Liaoning, Jiangsu and Hainan.

The company's main business products cover cardiovascular and cerebrovascular diseases, tumors, orthopedics, pediatrics, gynecology and other major diseases. The core varieties include Baise Tongshenxiong Glucose Injection, Jingang elemene injection, Bai Bei Sodium Hyaluronate Injection, Tirofiban Sodium Chloride Injection and so on.

Won "Top 20 100 Pharmaceutical Industry in China", "Top 20 100 Pharmaceutical Industry in China", "Top 20 100 Pharmaceutical Industry in China" and "Top 20 100 Pharmaceutical Industry in".